Abstract
Background: Argireline is an innovative neuropeptide widely applied topically on the skin. Its structure resembles the N-terminal end of the synaptic protein SNAP-25, and so inhibits the formation of SNARE complex and reduces the release of the neurotransmitter acetylcholine. These properties are used in cosmetic formulations to reduce facial muscle contractions, thus preventing the formation of expressive wrinkles, mainly on the forehead and around eyes.
Methodology: Argireline is a biomimetic peptide whose effect has been confirmed. When used at a concentration of 5-10%, its therapeutic activity is similar to that of botulinum toxin but without its side effects. This biologically-active ingredient is used for daily home care (good penetration of emulsion W/O/W) and in beauty salons to facilitate penetration of peptides through the skin (dermarollery, iontophoresis). Conclusion: The article presents recent data concerning the value of argireline as a highly important synthetic molecule which affects the mechanical properties of the skin.Keywords: Argireline, hexapeptide, mimic wrinkles, SNARE complex, botulinum toxin, skin.
Letters in Drug Design & Discovery
Title:The Peptide Argireline-The Importance of Local Application on the Skin, in the Light of Current Knowledge
Volume: 14 Issue: 10
Author(s): Agnieszka Dana and Helena Rotsztejn*
Affiliation:
- Department of Cosmetology and Aesthetic Dermatology, Faculty of Pharmacy, Medical University of Lodz, Lindleya 6, 90-151 Lodz,Poland
Keywords: Argireline, hexapeptide, mimic wrinkles, SNARE complex, botulinum toxin, skin.
Abstract: Background: Argireline is an innovative neuropeptide widely applied topically on the skin. Its structure resembles the N-terminal end of the synaptic protein SNAP-25, and so inhibits the formation of SNARE complex and reduces the release of the neurotransmitter acetylcholine. These properties are used in cosmetic formulations to reduce facial muscle contractions, thus preventing the formation of expressive wrinkles, mainly on the forehead and around eyes.
Methodology: Argireline is a biomimetic peptide whose effect has been confirmed. When used at a concentration of 5-10%, its therapeutic activity is similar to that of botulinum toxin but without its side effects. This biologically-active ingredient is used for daily home care (good penetration of emulsion W/O/W) and in beauty salons to facilitate penetration of peptides through the skin (dermarollery, iontophoresis). Conclusion: The article presents recent data concerning the value of argireline as a highly important synthetic molecule which affects the mechanical properties of the skin.Export Options
About this article
Cite this article as:
Dana Agnieszka and Rotsztejn Helena *, The Peptide Argireline-The Importance of Local Application on the Skin, in the Light of Current Knowledge, Letters in Drug Design & Discovery 2017; 14 (10) . https://dx.doi.org/10.2174/1570180814666170419121210
DOI https://dx.doi.org/10.2174/1570180814666170419121210 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Clinical Pharmacokinetics of Irinotecan-Based Chemotherapy in Colorectal Cancer Patients
Current Clinical Pharmacology The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Non-Melanoma Skin Cancer – Overview
Current Cancer Therapy Reviews Chemical Toxicity on HeLa Cells
Current Medicinal Chemistry The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Current Medicinal Chemistry Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry Copper Homeostasis for the Developmental Progression of Intraerythrocytic Malarial Parasite
Current Topics in Medicinal Chemistry Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway
Current Drug Discovery Technologies Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds
Current Medicinal Chemistry DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Literature Review: Use of Family History for Primary Paediatric Care as the Next Step Towards use of Genomics in Healthcare
Current Pediatric Reviews Vitamin D Represses the Aggressive Potential of Osteosarcoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions
Current Chemical Biology The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry New Insights on the Antitumoral Properties of Prodiginines
Current Medicinal Chemistry